On the evening of April 26, Jiang Rensheng, the actual controller of Zhifei Biology, and Jiang Xisheng, the person acting in concert, reduced their holdings of 16.411 million shares and 1 million shares, respectively, by 1.03% and 0.06%, totaling 1.09%. On that day, Zhifei Biology’s share price was 203 yuan. Based on this calculation, the reduction in holdings was 3.331 billion yuan and 203 million yuan.
The announcement shows that after the reduction, the actual controller Jiang Rensheng's shareholding fell to 802 million shares, and the shareholding ratio fell to 50.11%. According to Capital State statistics, in April two years ago (2019), Jiang Rensheng held 866 million shares, which was 54.13% at that time. In the past two years, Jiang Rensheng reduced his shareholding ratio by 4%. In the past two years, Zhifei Bio's stock price has risen all the way. Since April 2019, Zhifei's share price has soared by 194%.
On April 20, Zhifei Bio-Bio released its 2020 annual report and the first quarterly report for 2021. In 2020, it achieved an operating income of 15.19 billion yuan, a year-on-year increase of 43.5%; net profit attributable to the parent company was 3.30 billion yuan, a year-on-year increase of 39.5%. In the first quarter of 2021, the operating income was 3.93 billion yuan, a year-on-year increase of 49.0%, and the net profit attributable to the parent company was 940 million yuan, a year-on-year increase of 81.7%
Comments
Post a Comment